Under the deal, Uniphar will serve as LYMPHIR’s exclusive distribution partner across designated Western and Eastern European territories
The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year
Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health security
Revenue from operations rose to Rs. 23,637 million for the three months ended December 31, 2025
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
The therapy is currently completing Phase 1 clinical trials in renal cell carcinoma and non-small cell lung cancer
Call it one of the most striking turnarounds in the Indian pharma sector this fiscal year
Semaglutide—a glucagon?like peptide?1 receptor agonist (GLP-1RA) sold as Ozempic and Rybelsus for type 2 diabetes, and Wegovy for weight management and cardiovascular risk reduction
Subscribe To Our Newsletter & Stay Updated
